Search results for "blas"

showing 10 items of 2217 documents

Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxin.

1990

The treatment of human diploid fibroblasts with tumor necrosis factor (TNF)-alpha and with lymphotoxin (LT) is associated with induction of interleukin-6 (IL-6) transcripts with TNF-alpha being 10-fold more potent than LT. Here we report on the TNF-alpha/LT-induced signaling mechanisms responsible for the regulation of IL-6 gene expression in these cells. Run-on assays demonstrated that both TNF-alpha and LT increase IL-6 mRNA levels by transcriptional activation of this gene. Stability studies of IL-6 transcripts in fibroblasts showed that TNF-alpha delayed IL-6 mRNA decay but not LT. The induction of IL-6 transcripts by TNF-alpha and LT was not inhibited by the isoquinoline sulfonamide de…

medicine.medical_specialtyTime FactorsTranscription Geneticmedicine.medical_treatmentCellular differentiationBiophysicsCycloheximideBiologyBiochemistrychemistry.chemical_compoundStructural BiologyInternal medicineGene expressionGeneticsmedicineHumansRNA MessengerMolecular BiologyLymphotoxin-alphaProtein kinase CCells CulturedProtein Kinase CInterleukin-6Tumor Necrosis Factor-alphaCell BiologyFibroblastsMolecular biologyKineticsCytokineLymphotoxinEndocrinologychemistryGene Expression RegulationProtein BiosynthesisTumor necrosis factor alphaSignal transductionFEBS letters
researchProduct

Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner – A quantitative in vitro gene expression analy…

2010

Bisphosphonates are widely used in the clinical treatment of bone diseases with increased bone resorption. In terms of side effects, they are known to be associated with osteonecrosis of the jaw (BONJ). There are two groups of bisphosphonates: the nitrogen-containing bisphosphonates, e.g. zoledronate and ibandronate, and the non-nitrogen-containing bisphosphonates, e.g. clodronate. Their impact on bone metabolism seems to differ. The objective of this study was to compare the osteogenic differentiation potency of these two pharmacologic groups. Human osteoblasts were stimulated with zoledronate and ibandronate at concentrations of 5×10(-5) M, 5×10(-6) M and 5×10(-7) M over the experimental …

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentOsteocalcinCell Culture TechniquesCore Binding Factor Alpha 1 SubunitZoledronic AcidIbandronic acidBone remodelingInternal medicineHumansMedicineIbandronic AcidHomeodomain ProteinsMSX1 Transcription FactorOsteoblastsBone Density Conservation AgentsDiphosphonatesDose-Response Relationship DrugbiologyReverse Transcriptase Polymerase Chain Reactionbusiness.industryImidazolesCell DifferentiationOsteoblastDLX5BisphosphonateRUNX2Zoledronic acidmedicine.anatomical_structureEndocrinologyGene Expression RegulationOtorhinolaryngologyOsteocalcinbiology.proteinSurgeryBone RemodelingClodronic AcidOral SurgerybusinessBiomarkersTranscription Factorsmedicine.drugJournal of Cranio-Maxillofacial Surgery
researchProduct

Therapeutic management of the odontogenic keratocyst. An energetic approach with a conservative perspective and review of the current therapeutic opt…

2020

Background Odontogenic keratocysts (OKC) are cystic lesions appearing in the jaws, usually asymptomatic with a progressive growth into the bone. Many of them are diagnosed by a routine radiological examination. Material and methods This study reports a 12-year-old girl that presented an asymptomatic large radiolucent unilocular lesion associated to the crown of 3.8 that caused displacement of the molar and the inferior alveolar canal. Differential diagnosis included OKC, unicystic ameloblastoma, ameloblastic fibroma, dentigerous cyst and orthokeratinized odontogenic cyst. Two surgical interventions were performed; first, a marsupialization, and 10 months after, the third molar extraction pl…

medicine.medical_specialtyUnicystic Ameloblastomamedicine.medical_treatmentEnucleationCase ReportQuistosCarnoy's solutionMucosa oral03 medical and health sciencesAmeloblastic fibroma0302 clinical medicinestomatognathic systemmedicineTeeth extractionCystKeratocystGeneral DentistryExtracció dentalOral Medicine and Pathologybusiness.industry030206 dentistryDent molarmedicine.diseaseMarsupialization:CIENCIAS MÉDICAS [UNESCO]MolarSurgeryDentigerous cystCysts (Pathology)stomatognathic diseases030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASOral mucosamedicine.symptombusinessJournal of Clinical and Experimental Dentistry
researchProduct

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

2005

The prognosis for young children with medulloblastoma is poor, and survivors are at high risk for cognitive deficits. We conducted a trial of the treatment of this brain tumor by intensive postoperative chemotherapy alone.After surgery, children received three cycles of intravenous chemotherapy (cyclophosphamide, vincristine, methotrexate, carboplatin, and etoposide) and intraventricular methotrexate. Treatment was terminated if a complete remission was achieved. Leukoencephalopathy and cognitive deficits were evaluated.Forty-three children were treated according to protocol. In children who had complete resection (17 patients), residual tumor (14), and macroscopic metastases (12), the five…

medicine.medical_specialtyVincristineCyclophosphamidemedicine.medical_treatmentIntelligenceBrain tumorNeuropsychological TestsCarboplatinchemistry.chemical_compoundAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansCerebellar NeoplasmsCyclophosphamideEtoposideEtoposideProportional Hazards ModelsMedulloblastomaPostoperative CareChemotherapyAnalysis of Variancebusiness.industryDesmoplastic medulloblastomaRemission InductionInfantGeneral Medicinemedicine.diseaseSurvival AnalysisCarboplatinSurgeryMethotrexatechemistryChemotherapy AdjuvantVincristineChild PreschoolNeoplasm Recurrence Localbusinessmedicine.drugFollow-Up StudiesMedulloblastomaThe New England journal of medicine
researchProduct

Esthesioneuroblastoma presenting with epifora in a young child

1997

Esthesioneuroblastoma (ENB) is an uncommon tumor believed to arise from the olfactory epithelium. 1 This neoplasm has rarely been reported in children, with only 12 cases reported to date among patients younger than 10 years. 2 The usual initial symptom in children, as in older patients, is nasal obstruction or epistaxis 3 ; consequently, the tumor is often first seen by an otorhinolaryngologist. We report a case of ENB in a young child in whom the initial symptom was epiphora; to our knowledge, this initial symptom is previously unreported, and ENB must now be considered in the differential diagnosis of epiphora in childhood. Report of a Case. A white 6-year-old male child was seen on Janu…

medicine.medical_specialtyYoung childOlfactory Neuroblastomabusiness.industryEye diseaseTopical antibioticsmedicine.diseaseDermatologySurgeryOphthalmologyEsthesioneuroblastomaOlder patientsMedicineMedical historyDifferential diagnosisbusinessUlls
researchProduct

Therapeutic laser guidelines: On the effects of laser radiation on human skin-fibroblast metabolism in culture

1989

A promising field of laser utilization is the modification of cell behaviour. Acting on cell biological functions it might be possible to use them to improve medical therapies. This possibility suggests investigation of dosimetry guidelines employing different wavelenghts, power and exposure durations for future potential use of lasers in medicine.

medicine.medical_specialtybusiness.industryCell behaviourDermatologyLaserlaw.inventionHuman skin fibroblastlawmedicineDosimetrySurgeryMedical physicsbusinessBiomedical engineeringLasers in Medical Science
researchProduct

Surgical management of ameloblastoma. Review of literature

2019

Background Ameloblastoma is an odontogenic tumor that represents 1% of all tumors in the oral cavity and it is clinically classified in three types. Currently, solid and multi-cystic are considered locally aggressive, with high recurrence rates with conservative treatment. Material and methods Objective of the present review is to assess whether the surgical treatment should be conservative or radical. English articles published between 2009-2014, with available summary and in humans were included. Results 241 articles were found, 188 were excluded because analyzing. 53 articles were analyzed and finally 14 were selected for this review. Conclusions The optimal surgical treatment of amelobl…

medicine.medical_specialtybusiness.industryGeneral surgeryEnucleationMEDLINEOdontogenic tumorReview030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOral cavitySurgical planningConservative treatment03 medical and health sciences0302 clinical medicineUNESCO::CIENCIAS MÉDICASMedicineOral Surgery030223 otorhinolaryngologybusinessAmeloblastomaSurgical treatmentGeneral Dentistry
researchProduct

Belastung und psychosoziale Betreuungsbedürftigkeit von Glioblastompatienten

2011

Glioblastoma patients should be provided with a professional health care system that helps reduce their psychosocial burden. The aim of this study was to identify patients in need of psychosocial intervention. In addition, it was examined whether physicians' assessments adequately address the burden patients are under and their need for intervention. During their visit to one of two neurosurgery outpatient departments, n = 49 glioblastoma patients filled out the short version of the Hornheider questionnaire (HFK). Consulting physicians also rated their patients' burdens in a specially adapted version of the questionnaire (HFK-F). The results of the psychometric evaluation with both instrume…

medicine.medical_specialtybusiness.industryState of healthmedicine.diseasePsychiatry and Mental healthClinical PsychologyIntervention (counseling)Health caremedicineNeurosurgeryPsychiatrybusinessPsychosocialApplied PsychologyGlioblastomaPPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie
researchProduct

Is Nephron Sparing Surgery Justified in Wilms Tumor With Beckwith-Wiedemann Syndrome or Isolated Hemihypertrophy?

2016

Background Patients with Beckwith–Wiedemann syndrome (BWS) or isolated hemihypertrophy (HH) treated for a Wilms tumor (WT) carry an increased risk of developing metachronous lesion. There are no guidelines on precise indications for nephron sparing surgery (NSS) in unilateral WT (UWT). The objective of this retrospective study was to delineate the indications of NSS in patients with BWS/HH treated for WT and to evaluate their outcome. Procedure All cases of BWS/HH treated for a WT according to SIOP protocols from 1980 to 2013 were reviewed. Patients were divided into two groups (G): isolated UWT (G1) and bilateral lesions (G2) with two subgroups: bilateral tumors suspected of malignancy (G2…

medicine.medical_specialtybusiness.industryUrologyBeckwith–Wiedemann syndromeRetrospective cohort studyWilms' tumorHematologyMalignancymedicine.diseaseSurgeryLesion03 medical and health sciences0302 clinical medicineOncology030225 pediatrics030220 oncology & carcinogenesisPediatrics Perinatology and Child Healthmedicinemedicine.symptomStage (cooking)businessNephroblastomatosisHemihypertrophyPediatric Blood & Cancer
researchProduct

An unusual fatal case of overdose of Vinblastine and review of literature

2017

The pharmacological treatment of neoplasia is based on the use of chemotherapeutic substances. Chemotherapeutic agents can cause acute and chronic toxicity even at therapeutic doses. For this reason their overdose puts a patient’s life at severe risk. This work presents an unusual fatal case of overdose subsequent to an accidental massive administration of Vinblastine (90 mg instead of 9 mg), slow bolus (five minutes), to a 33-year-old woman who suffered from Hodgkin’s Lymphoma. The administration of the massive dose was due to a transcription error of the therapeutic treatment plan and miscommunication between the health professionals which caused the use of the wrong dose. The foren…

medicine.medical_specialtydeath; intoxication; medical malpractice; overdose; Vinblastine; 2734Therapeutic treatment2734Poison controlmedical malpracticeVinblastinePathology and Forensic MedicinePharmacological treatment03 medical and health sciences0302 clinical medicineBolus (medicine)intoxicationdeathmedicine030216 legal & forensic medicineIntensive care medicineChronic toxicitybusiness.industrymedicine.diseaseLymphomaVinblastineSurgery030220 oncology & carcinogenesisAccidentaloverdosebusinessmedicine.drug
researchProduct